BiotechTube
Home/Kovina Therapeutics/Kristin Sherman
KS

Kristin Sherman

CEO

Kovina Therapeutics

Therapeutic Areas

OncologyInfectious Disease

Kovina Therapeutics Pipeline

DrugIndicationPhase
HPV E6 Inhibitor ProgramHPV-driven Cancers (e.g., Cervical, Oropharyngeal)Preclinical

Leadership Team at Kovina Therapeutics

EA
Elliot Androphy, M.D.
Founder, Chief Scientific Officer
ZL
Zhijian Lu, Ph.D.
Founder, Vice President, Medicinal Chemistry
CB
Colleen Beeler, CPA
Vice President, Finance
PS
Paddy Shivanand, Ph.D.
Vice President, CMC
View full Kovina Therapeutics profile